RxDoctor Payments DataLook up a doctor →

Alan Schwartz, MD

Pulmonary Disease · Baltimore, MDNPI 1639194392

Payments from drug & device makers

$1,568,763in general payments, 2019–2025

Across 385 payments — averaging $4074.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Itamar Medical Inc$867K
  • Livanova USA, Inc.$301K
  • ZOLL Respicardia, Inc.$261K
  • Philips North America LLC$108K
  • Takeda Pharmaceuticals U.S.A., Inc.$18K
  • Jazz Pharmaceuticals Inc.$5K
  • plus $9K from 39 others
$67,382in research payments, 2019–2025

Across 7 payments — averaging $9626.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Livanova USA, Inc.$34K
  • Philips North America LLC$33K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,568,763 in reported general payments places this provider in the 95th percentile of 297 pulmonary disease providers in Maryland.

See all pulmonary disease providers in Maryland

Medicare billing

Part B allowed, 2024
$89,809
Medicare patients
268
Services billed
433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →